Ovarian Cancer Clinical Trials

Trials for someone you care about with ovarian cancer.

Cancer

RecruitingDrugDeviceBehavioralOlder adultsHealthy volunteers

21 trials

Comparing Bilateral Salpingectomy with Bilateral Salpingectomy with for ovarian carcinoma

Explore this study →

There are 2 groups in this study. Group A receives Bilateral Salpingectomy, together with one or more of: Biospecimen Collection, Magnetic Resonance Imaging, Quality-of-Life Assessment, Questionnaire Administration, Transvaginal Ultrasound and Ultrasound Imaging. Group B, the comparison group, receives one or more of: Bilateral Salpingectomy with Oophorectomy, Biospecimen Collection, Magnetic Resonance Imaging, Quality-of-Life Assessment, Questionnaire Administration, Transvaginal Ultrasound and Ultrasound Imaging.

Sites in Montreal and Vancouver

  • 2 groups
  • Sites in Vancouver and Montreal
  • Recruiting

Official title: A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma · NRG Oncology

Comparing 3 approaches for ovarian cancer

Explore this study →

There are 3 groups in this study. Group A receives Sacituzumab tirumotecan and Bevacizumab, together with one or more of: H1 receptor antagonist, H2 receptor antagonist, Acetaminophen (or equivalent), Dexamethasone (or equivalent) and Steroid mouthwash (dexamethasone or equivalent). Group B receives Sacituzumab tirumotecan, together with one or more of: Bevacizumab, H1 receptor antagonist, H2 receptor antagonist, Acetaminophen (or equivalent), Dexamethasone (or equivalent) and Steroid mouthwash (dexamethasone or equivalent). Group C, the comparison group, receives Bevacizumab.

Sites in Montreal, Calgary and 3 more cities

  • Phase 3
  • 3 groups
  • Sites in Calgary, Greater Sudbury and 3 more cities
  • Recruiting

Official title: A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Ovarian Cancer · Merck Sharp & Dohme LLC

Looking for the closest fit?

Get matched →

Ask someone to look with you

Whether or not the results above are what you were looking for, someone at Concord can search with you.

Get notified when a matching trial opens

We'll watch for Ovarian Cancer trials near you.

Ovarian Cancer
Want matched now instead? →
← Back to all conditions

Concord provides information support only. Trial listings come from public registries; eligibility is always determined by the trial site and your care team.